BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1446596)

  • 1. Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor.
    Roos F; Terrell TG; Godowski PJ; Chamow SM; Schwall RH
    Endocrinology; 1992 Dec; 131(6):2540-4. PubMed ID: 1446596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of Calculus Bovis Sativus on intrahepatic cholestasis in rats induced by α-naphthylisothiocyanate.
    Wu T; Chang MJ; Xu YJ; Li XP; Du G; Liu D
    Am J Chin Med; 2013; 41(6):1393-405. PubMed ID: 24228608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary metabolic fingerprinting for alpha-naphthylisothiocyanate-induced intrahepatic cholestasis in rats using Fourier transform-ion cyclotron resonance mass spectrometry.
    Hasegawa M; Ide M; Fujita T; Takenaka S
    Toxicol Pathol; 2008 Oct; 36(6):818-26. PubMed ID: 18776161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibitory effect of SA3443, a novel cyclic disulfide compound, on alpha-naphthyl isothiocyanate-induced intrahepatic cholestasis in rats.
    Tanaka M; Nakata K; Mita S
    Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):543-7. PubMed ID: 8222333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between alpha-naphthylisothiocyanate-induced liver injury and elevations in hepatic non-protein sulfhydryl content.
    Dahm LJ; Bailie MB; Roth RA
    Biochem Pharmacol; 1991 Aug; 42(6):1189-94. PubMed ID: 1679630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of compound Yindan decoction on alpha-naphthylisothiocyanate-Induced acute intrahepatic cholestasis in rats.
    Sun F; Li X; Xu C; Li P; Wu J; Sui J
    J Tradit Chin Med; 2019 Jun; 39(3):315-323. PubMed ID: 32186003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo.
    Ishiki Y; Ohnishi H; Muto Y; Matsumoto K; Nakamura T
    Hepatology; 1992 Nov; 16(5):1227-35. PubMed ID: 1427661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of emodin on P-gp expression in intrahepatic cholestatic rats].
    Zhou F; Xu H
    Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):908-11. PubMed ID: 20575398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against alpha-naphthylisothiocyanate-induced liver injury by decreased hepatic non-protein sulfhydryl content.
    Dahm LJ; Roth RA
    Biochem Pharmacol; 1991 Aug; 42(6):1181-8. PubMed ID: 1679629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
    J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited protective role of V-PYRRO/NO against cholestasis produced by alpha-naphthylisothiocyanate in mice.
    Liu J; He YY; Chignell CF; Clark J; Myers P; Saavedra JE; Waalkes MP
    Biochem Pharmacol; 2005 Jul; 70(1):144-51. PubMed ID: 15913567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 16,16-dimethyl-PGE2 protection against alpha-naphthylisothiocyanate-induced experimental cholangitis in the rat.
    Ruwart MJ; Rush BD; Friedle NM; Stachura J; Tarnawski A
    Hepatology; 1984; 4(4):658-60. PubMed ID: 6745853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
    Khamphaya T; Chansela P; Piyachaturawat P; Suksamrarn A; Nathanson MH; Weerachayaphorn J
    Eur J Pharmacol; 2016 Oct; 789():254-264. PubMed ID: 27475677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large dose means significant effect--dose and effect relationship of Chi-Dan-Tui-Huang decoction on alpha-naphthylisothiocyanate-induced cholestatic hepatitis in rats.
    Zhao Y; Ma X; Wang J; Wen R; Jia L; Zhu Y; Li R; Wang R; Li J; Wang L; Li Y; Xiao X
    BMC Complement Altern Med; 2015 Apr; 15():104. PubMed ID: 25889085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
    Thatch KA; Katz MS; Haber MM; Schwartz MZ
    J Pediatr Surg; 2010 Jan; 45(1):89-94. PubMed ID: 20105586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of betaine supplementation on changes in hepatic metabolism of sulfur-containing amino acids and experimental cholestasis induced by alpha-naphthylisothiocyanate.
    Kim YC; Jung YS; Kim SK
    Food Chem Toxicol; 2005 May; 43(5):663-70. PubMed ID: 15778005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HGF induces protective effects in α-naphthylisothiocyanate-induced intrahepatic cholestasis by counteracting oxidative stress.
    Salas-Silva S; Simoni-Nieves A; Razori MV; López-Ramirez J; Barrera-Chimal J; Lazzarini R; Bello O; Souza V; Miranda-Labra RU; Gutiérrez-Ruiz MC; Gomez-Quiroz LE; Roma MG; Bucio-Ortiz L
    Biochem Pharmacol; 2020 Apr; 174():113812. PubMed ID: 31954718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Echinochrome against intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.
    Fahmy SR; Sayed DA; Soliman AM; Almortada NY; Aal WEA
    Braz J Biol; 2020; 80(1):102-111. PubMed ID: 31017240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Zhao YL; Wang JB; Zhou GD; Shan LM; Xiao XH
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):463-9. PubMed ID: 19389047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
    Thatch KA; Schwartz MZ; Yoo EY; Mendelson KG; Duke DS
    J Pediatr Surg; 2008 Dec; 43(12):2169-73. PubMed ID: 19040928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.